Different Covid-19 Vaccines in Pakistan: Administration and Effectiveness

Authors

  • Anwaar Iftikhar Centre for Applied Molecular Biology (CAMB), University of the Punjab, Quaid-e-Azam Campus, Lahore, Pakistan.
  • Muhammad Farooq Sabar Centre for Applied Molecular Biology (CAMB), University of the Punjab, Quaid-e-Azam Campus, Lahore, Pakistan.
  • Quart ul Ain Ahmad Department of Zoology, University of Education, Lahore, Pakistan.
  • Rida Farooq Centre for Applied Molecular Biology (CAMB), University of the Punjab, Quaid-e-Azam Campus, Lahore, Pakistan.
  • Mubeen Akhtar Centre for Applied Molecular Biology (CAMB), University of the Punjab, Quaid-e-Azam Campus, Lahore, Pakistan.

Keywords:

Covid-19, Vaccines, Sinopharm, Sputnik V, CoronaVac Pfizer, Moderna, Administration, Effectiveness, China, Russia

Abstract

Pfizer-BioNTech, Moderna, Sputnik V (typically manufactured in Russia), CoronaVac (China), Sinopharm (China), Vaxzevria, and Cansino (both made in China) are among the vaccines that have been certified for emergency use in several countries. All of the above vaccinations were authorized to Pakistan, bypassing Pfizer and Moderna. The effectiveness, safety, mechanism of action, dosage, and availability of mandatory vaccines in Pakistan up to May 20, 2021. We searched PubMed and Google Scholar for all known material on COVID-19 vaccinations. We also looked at grey literature papers. Instead of Pfizer and Moderna, Pakistan has approved all the preceding vaccines. Moderna and Pfizer were determined to be the most effective among all vaccinations, with 90% effectiveness, followed by Vaxzevria, Sputnik V, Sinopharm, and Cansino. All immunizations have caused lesser bad effects like fever, injection site pain, or headaches. Further clinical studies are being done throughout the world to combat the epidemic. In large populations, public attention plays a critical role in vaccination efforts.

Downloads

Published

2023-09-22

How to Cite

1.
Iftikhar A, Sabar MF, Ahmad Q ul A, Farooq R, Akhtar M. Different Covid-19 Vaccines in Pakistan: Administration and Effectiveness. Nat J Health Sci [Internet]. 2023Sep.22 [cited 2024May29];8(3):132-6. Available from: https://ojs.njhsciences.com/index.php/njhs/article/view/455

Issue

Section

Review Article